Add To Watchlist
Share URL
About The Company
CEO
Mr. Mattias Perjos M.Sc.
Market Cap
62.18 Billion SEK
Sector
Healthcare
Website
https://www.getinge.comDescription
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments.
Read More
Overview
Value
66
Growth
60
Health
45
Management
48
Analyst Opinion
86
Total
61
All Scores Out Of 100
Best Features
- Very strong cashflow and earnings growth
- Has a low level of debt
- Low risk of bankruptcy
- Has a margin-of-safety above fair value
- Liked by analysts
- Has strong dividend growth
Risk Factors
- Earnings have declined recently
- Price-to-earnings ratio of 22.8 is higher than the market average (19.6x)
Market Peers
GETI-B.ST
Key Figures
PE Ratio (TTM)
22.84
Margin Of Safety (DCF)
189.98%
Revenue Growth (5 Year Average)
12.17%
Ratings Consensus
Strong Buy
Share Buybacks
N/A
Dividend Yeild (TTM)
1.82%
Valuation
Value Score
66
- ✔ Margin-of-safety of 189.98% is better than the market average (17.95%)
- ✔ Estimated intrinsic-value of 657.68 SEK is higher than current price ( 228.30 SEK)
- ✘ Price-to-earnings ratio of 22.8 is higher than the market average (19.6x)
- ✘ Free-cashflow-yeild of 4.59% is worse than the market average (4.7%)
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 407.8 SEK ✔
Current Price: 226.8 SEK
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
22.84x
Free Cashflow Yeild
4.59%
PE/Earnings Growth
N/A
Price/Book
2.00x
Growth
Growth Score
60
- ✔ 5 Year Average Revenue growth of 12.17% is higher than the market average (10.97%)
- ✔ 5 Year Average Cashflow growth of 24.78% is higher than the market average (12.35%)
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Earnings growth of 8.29% is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
12.17%
Earnings Growth
8.29%
Cashflow Growth
24.78%
Health
Health Score
45
Altman Z Score
3.40
Piostroski Score
5.00
Debt/Equity
0.17x
Current Assets/Liabilities
1.42x
Free Cashflow/Total Debt
1.31x
Debt/Capital
0.29x
Dividend
Secure Dividend Score
59
- ✔ Dividend is likely safe
- ✔ Long term dividend payout ratio of 5.70% is considered good
- ✔ Dividends have shown growth over the last 5 years
- ✔ Dividend growth has been accelerating recently
- ✘ Dividend yeild of 1.82% is less than the market average (1.85%)
- ✘ Payout ratio (TTM) of 41.63% is higher than the average (40%)
- ✘ Spending a higher percentage of their income on dividends than last 5 years
Dividend Yeild
1.82%
Dividend Growth
24.63%
Payout Ratio (Earnings)
41.63%
Payout Ratio (Cashflow)
39.74%
Management
Management Score
48
Average Buybacks/Dilution
N/A
Recent Buybacks/Dilution
0.00%
5 Year Price Volitility
50.13%
Return On Assets
6.66%
Return On Capital Employed
14.39%
Return On Equity
12.00%
Return On Free Cashflow
48.24%
Return On Investments
N/A
Analysts
Analyst Opinion
86
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Currency
SEK
Beta
Vol Avg
Ceo
Mr. Mattias Perjos M.Sc.
Cik
Cusip
Exchange
Stockholm Stock Exchange
Full Time Employees
Industry
Medical Devices
Sector
Healthcare
Ipo Date
Address
Lindholmspiren 7A
City
Gothenburg
State
Country
Zip
417 56
Phone
46 1 03 35 00 00
All financial data provided by FMP